A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone
A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone
The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone.
Inclusion Criteria:
Exclusion Criteria:
Anaheim, California 92804-3738, United States
Garden Grove, California 92845, United States
Sherman Oaks, California 91403-2109, United States
Ottawa, Ontario K1Z 1G3, Canada
Gdansk, Pomeranian Voivodeship 80-546, Poland
Szczecin, West Pomeranian Voivodeship 70-486, Poland
Bia?ystok, 15-464, Poland
Bialystok, 15-404, Poland
Bełchatów, Łódź Voivodeship 97-400, Poland
Novi Kneževac, 23330, Serbia
Liptovský Mikuláš, 031 23, Slovakia